JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 46 filers reported holding JANUX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,823,593 | -16.8% | 2,067,468 | -2.0% | 0.01% | -12.5% |
| Q2 2023 | $25,031,210 | +10.7% | 2,109,338 | +12.9% | 0.02% | +6.7% |
| Q1 2023 | $22,611,527 | -6.5% | 1,869,076 | +1.7% | 0.02% | -11.8% |
| Q4 2022 | $24,173,460 | -9.0% | 1,837,791 | -53.1% | 0.02% | -15.0% |
| Q3 2022 | $26,572,546 | +2.3% | 3,920,088 | +84.2% | 0.02% | +11.1% |
| Q2 2022 | $25,966,000 | -22.6% | 2,127,797 | -9.0% | 0.02% | +12.5% |
| Q1 2022 | $33,542,000 | -28.0% | 2,339,146 | -2.6% | 0.02% | -15.8% |
| Q4 2021 | $46,558,000 | -9.4% | 2,400,893 | -0.6% | 0.02% | -13.6% |
| Q3 2021 | $51,375,000 | -20.4% | 2,416,404 | -9.4% | 0.02% | -21.4% |
| Q2 2021 | $64,522,000 | – | 2,668,207 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $104,914,792 | 2.38% |
| EcoR1 Capital, LLC | 3,838,486 | $46,445,681 | 1.50% |
| Samsara BioCapital, LLC | 360,414 | $4,361,009 | 0.90% |
| BVF INC/IL | 1,585,677 | $19,186,692 | 0.70% |
| Orbimed Advisors | 2,836,386 | $34,320,271 | 0.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,000 | $10,890,000 | 0.02% |
| Woodline Partners LP | 137,300 | $1,661,330 | 0.02% |
| Vident Investment Advisory, LLC | 55,483 | $671,344 | 0.02% |
| JANUS HENDERSON GROUP PLC | 1,869,076 | $22,611,527 | 0.02% |
| FMR LLC | 10,281,288 | $124,403,584 | 0.01% |